Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp. (NYSE: ORIA) is a blank-check company that completed its initial public offering in 2021, targeting acquisition opportunities in the biotechnology and life sciences sector. The SPAC was sponsored by Orion Biotech Opportunities LLC, an entity affiliated with OrbiMed Advisors, a specialist healthcare investment firm with a long track record in biopharmaceutical investing. The company filed an 8-K with the SEC on May 18, 2021, bearing accession number 0001213900-21-027520, during its post-IPO search period. ORIA was listed on the New York Stock Exchange and focused its deal mandate on innovative life sciences businesses. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time deal tracking on ORIA and hundreds of other SPACs.